Key Highlights

  • HUN third-quarter 2026 Revenue reached $1,717 million, compared with $1,460 million in the same period last year, an 18% gain.
  • A net loss attributable to Huntsman was $18 million, which works out to $0.10 a diluted share, after $25 million ($0.14 a share) a year earlier.
  • Adjusted EBITDA reached $132 million, versus $94 million a year earlier, and adjusted Net Income swung to $7 million from a $5 million adjusted loss.
  • Free Cash Flow dropped to $82 million from $157 million a year before.
  • Management now anticipates the combination with the other chemicals producer closing during Q1 2027.

Pricing Strength and Added Volume Push the Top Line 18% Higher as Losses Shrink

On Nov 2, 2026, Huntsman (NYSE:HUN) published its Q3 2026 figures. Revenue came in at $1,717 million compared with $1,460 million a year before. The attributable loss narrowed to $18 million, equal to $0.10 a diluted share, against $25 million ($0.14 a share) during Q3 2025.

Huntsman manufactures diversified chemicals for consumer and industrial customers, reporting roughly $6 billion of 2025 revenue from continuing operations.

Operating income reached $39 million compared with $6 million previously, while Gross Profit climbed from $204 million to $237 million. Higher average selling prices supplied 15 percentage points of the 18% revenue increase, and volume added 3 points.

Segment Gains in Polyurethanes and Advanced Materials Drive Adjusted EBITDA Higher

Adjusted EBITDA stood at $132 million versus $94 million previously, about 40% higher on a calculated basis. On the adjusted per-share measure, the company earned $0.04 against a $0.03 loss, and adjusted net income moved from a $5 million loss to $7 million of profit.

The polyurethanes Business posted $1,152 million in revenue, up 21%, thanks to MDI pricing gains across all three regions and stronger volumes in the Americas and Europe. Its segment adjusted EBITDA reached $75 million, a 56% increase, supported by larger Equity income from a minority-owned China joint venture and cost-program savings.

Advanced Materials sales reached $314 million, an 18% increase, as volume grew in aerospace, automotive and power end markets. Adjusted EBITDA for the unit grew 41%, reaching $62 million. Performance Products generated $260 million, up 6%, driven by pricing and product mix.

Lower Cash Generation and Rising Net Debt Frame a Near-4 Times Leverage Goal

Continuing operations generated $115 million of operating cash, down from $200 million a year before. Free cash flow landed at $82 million against $157 million. Across nine months it fell into negative territory at $99 million, versus $105 million of positive cash generation, because Working Capital used up $189 million.

At Sep 30, 2026 net debt stood at $1,684 million, compared with $1,582 million on Dec 31, 2025. Total debt was $2,043 million, cash $359 million, and combined cash plus undrawn borrowing capacity roughly $0.9 billion.

Capex was $33 million in the quarter, with about $160 million projected for 2026. Leadership sees net debt leverage reaching roughly 4 times at year end, helped by stronger Earnings and cash flow.

Shareholder and Regulatory Clearances Clear the Path, Closing Shifts Into 2027

Holders signed off on the combination with another chemical manufacturer on Aug 25, 2026. Authorities in several regions, the US among them, have granted clearance. Completion is now anticipated during the first quarter of 2027, subject to the outstanding approvals, and the merged entity would list under NYSE:OHN.

Nine-month sales totaled $4,800 million, up 11%, the net loss narrowed to $77 million from $188 million, and adjusted EBITDA reached $325 million versus $240 million.